Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 1/2 1

Status

Completed 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER_GOV 2OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 13Breast 9Thoracic 7Genitourinary 6Gynecologic 4CNS 4Lymphoid 3Other solid neoplasm 2Dermatologic 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Urinary Bladder Neoplasms 2Pain, Postoperative 1Erectile Dysfunction 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 161Specimen Handling 134enzalutamide 125Nivolumab 118Gemcitabine 96Docetaxel 92Radiosurgery 91Prednisone 81Androgen Antagonists 81Abiraterone Acetate 79Radiotherapy 75apalutamide 66Cisplatin 65darolutamide 62Ipilimumab 61Biopsy 61abiraterone 57cabozantinib 55Carboplatin 55Leuprolide 52enfortumab vedotin 50Radiation 47Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 38acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Saline Solution × Genitourinary × 1 year × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT03142334 2026-03-10

KEYNOTE-564

Merck Sharp & Dohme LLC

Phase 3 Completed
994 enrolled 10 charts 1 FDA
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT07445451 2026-03-03

TURBT

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Phase NA Completed
93 enrolled
Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

NCT07125924 2025-08-15

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

National Cancer Center, Korea

Phase NA Not yet recruiting
54 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03834493 2025-07-18

KEYNOTE-641

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
1,244 enrolled 21 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Completed
1,030 enrolled 24 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡